kinase lkb1 mediates glucose homeostasis liver therapeutic effects metformin
peutz-jegher syndrome tumor-suppressor gene encodes protein-threonine kinase lkb1 phosphorylates activates ampk [adenosine monophosphate amp-activated protein kinase] deletion lkb1 liver adult mice resulted nearly complete loss ampk activity loss lkb1 function resulted hyperglycemia increased gluconeogenic lipogenic gene expression lkb1-deficient livers torc2 transcriptional coactivator creb camp response element-binding protein dephosphorylated entered nucleus driving expression peroxisome proliferator-activated receptor-gamma coactivator alpha pgc alpha turn drives gluconeogenesis adenoviral small hairpin rna shrna torc2 reduced pgc alpha expression normalized blood glucose levels mice deleted liver lkb1 indicating torc2 critical target lkb1/ampk signals regulation gluconeogenesis finally show metformin one widely prescribed type diabetes therapeutics requires lkb1 liver lower blood glucose levels
